What is the recommended dose of polymyxin B (antibiotic) for a 3-year-old pediatric patient with conjunctivitis and no significant past medical history?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Polymyxin B Dosing for Pediatric Conjunctivitis

For a 3-year-old child with bacterial conjunctivitis, administer polymyxin B combination eye drops (polymyxin B/trimethoprim) 1 drop in the affected eye(s) every 3 hours while awake (maximum 6 doses per day) for 7-10 days. 1

Dosing Regimen

  • Standard dosing: Instill 1 drop every 3 hours (maximum 6 doses daily) for 7-10 days 1
  • This translates to approximately 4-6 times daily dosing in practical outpatient settings 2, 3
  • Treatment duration should be 7 days minimum, with clinical reassessment at 3-4 days 4, 5

Evidence Supporting Polymyxin-Based Therapy

Polymyxin B combinations (polymyxin-bacitracin or polymyxin-trimethoprim) are well-established alternatives to fluoroquinolones for pediatric bacterial conjunctivitis:

  • Clinical efficacy: In a randomized controlled trial of 102 children, polymyxin-bacitracin achieved 62% clinical cure by days 3-5 versus 28% with placebo (P<0.02), and 91% cure by days 8-10 2
  • Bacterial eradication: Polymyxin-bacitracin eradicated bacterial pathogens in 71% by day 3-5 and 79% by day 8-10, compared to only 19% and 31% with placebo (P<0.001) 2
  • Broad-spectrum coverage: Polymyxin B/trimethoprim provides both gram-positive and gram-negative activity against the most common pediatric pathogens (Haemophilus influenzae and Streptococcus pneumoniae) 3
  • Real-world effectiveness: A survey of 472 children treated with polymyxin B/trimethoprim showed 95% were cured or improved within 7 days, with excellent or good efficacy rated in 96% of cases 3

Important Clinical Context

While fluoroquinolones (moxifloxacin, levofloxacin) are considered first-line therapy for children >12 months 4, 5, polymyxin B combinations remain highly effective second-line options when:

  • Fluoroquinolones are unavailable or cost-prohibitive 4
  • There are concerns about fluoroquinolone resistance patterns 6
  • Parents prefer older, well-established medications 3

Critical Red Flags Requiring Immediate Ophthalmology Referral

Do NOT treat with topical antibiotics alone if any of the following are present:

  • Visual loss or moderate-to-severe pain 4, 5
  • Corneal involvement (infiltrate, ulcer, or opacity) 4, 5
  • Severe purulent discharge suggesting gonococcal infection—requires systemic ceftriaxone 125 mg IM plus topical therapy 4, 5
  • Age <1 month (neonatal conjunctivitis requires systemic treatment) 6, 5
  • No improvement after 3-4 days of appropriate topical therapy 4, 5

Special Considerations for Gonococcal and Chlamydial Infections

If gonococcal or chlamydial conjunctivitis is suspected (severe purulent discharge, sexual abuse history):

  • Gonococcal: Requires ceftriaxone 125 mg IM (for children <45 kg) plus azithromycin 1g PO, with daily follow-up until resolution 4, 5
  • Chlamydial: Requires systemic erythromycin 50 mg/kg/day divided into 4 doses for 14 days (children <45 kg) 4, 5
  • Mandatory: Consider and report suspected sexual abuse in any child with these infections 4, 6, 5

Follow-Up and Patient Education

  • Reassess at 3-4 days if no improvement; consider resistant organisms or alternative diagnoses 4, 5
  • Hand hygiene is critical to prevent transmission 4, 5
  • Return to school/daycare is permitted after 24 hours of treatment when symptoms begin improving 4
  • Avoid sharing towels or close contact during the contagious period 5

Common Pitfall to Avoid

Do not use oral antibiotics (such as cefixime) for routine bacterial conjunctivitis—a randomized trial showed oral cefixime was not superior to topical polymyxin-bacitracin for clinical cure or prevention of acute otitis media 7. Systemic antibiotics are reserved exclusively for gonococcal and chlamydial infections 6.

References

Guideline

Treatment of Pediatric Conjunctivitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Bacterial Conjunctivitis in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Conjunctivitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Short term oral cefixime therapy for treatment of bacterial conjunctivitis.

The Pediatric infectious disease journal, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.